Strides Pharma Science has sold a majority stake in its subsidiary, Pivot Path, to an Ascent Capital-led investor consortium for INR 100 crore, alongside a fresh INR 50 crore capital infusion that will support the company's expansion as an independent life sciences and digital transformation services provider.
Agentic AI | 29/06/2026 | By News Bureau
Owkin and Sanofi Partner to Develop AI Agents for Drug Discovery
Owkin and Sanofi have expanded their multi-year K Pro collaboration to develop AI agents that enhance drug discovery and development. By integrating agentic AI systems into research workflows, the partnership aims to unlock the full value of data, improve decision-making, and accelerate the development of innovative therapies.
Agentic AI | 06/06/2026 | By News Bureau | 116
Variant Bio Launches World's First Agentic AI Genomic Drug Discovery Platform
The agentic AI platform by Variant Bio, named Inference, brings together genetic and multi-omic data with autonomous analysis capabilities, and is already powering pharmaceutical partnerships totaling over USD 200 million.
Agentic AI | 09/01/2026 | By News Bureau | 380
Qure.ai Partners with Microsoft to Expand Lung Cancer AI Access in the US
Qure.ai has partnered with Microsoft to broaden access to its advanced lung cancer detection and management AI suite across the US. The collaboration integrates Qure.ai’s LLM- and agentic AI–driven tools into clinical workflows, helping radiology and pulmonology teams accelerate patient detection, diagnosis, and treatment pathways.
Agentic AI | 20/11/2025 | By Dineshwori | 245
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy